As mystery deepens over the cause of Alzheimer's, researchers seek new answers

June 6, 2018 by Charlotte Hsu, University at Buffalo
Shermali Gunawardena. Credit: Douglas Levere/University at Buffalo

For more than 20 years, much of the leading research on Alzheimer's disease has been guided by the "amyloid hypothesis."

This theory focuses on one of the disease's most salient traits: the formation of unusual plaques—or buildups of protein—in patients' brains. In Alzheimer's, these plaques are made from a protein known as beta-amyloid. As a result, many scientists believe that removing beta-amyloid or inhibiting its clumping should help to stave off dementia.

But with a series of failed clinical trials raising questions about this premise, some researchers are looking for deeper explanations into the causes of Alzheimer's and how this debilitating condition can be treated.

University at Buffalo biologist Shermali Gunawardena is among these investigators.

Her lab studies axonal transport—the complicated, internal highway system that conveys precious, life-giving materials from one part of a nerve cell to another. (Nerve cells, also called neurons, are a category of cells that include brain .)

Breakdowns in this transport system can lead to "traffic jams," and some scientists hypothesize that such blockages precede the formation of plaques in neurological diseases like Alzheimer's, Gunawardena says.

Using the neurons of , her team has been researching the role of —another Alzheimer's-linked protein—in axonal transport for several years, with the latest results published on May 22 in the journal Human Molecular Genetics.

"We are looking at processes that occur before cell death, before you start to see plaques in the brain," says Gunawardena, Ph.D., an associate professor of biological sciences in the UB College of Arts and Sciences. "A lot of the treatments being developed for Alzheimer's are targeting beta-amyloid, but maybe we should be targeting processes that happen earlier on, before plaques are formed."

A cell traffic controller

Gunawardena and colleagues have been publishing on presenilin and since 2013.

Their first study on the topic showed that presenilin helps to regulate the flow of traffic in fruit fly neurons, influencing how quickly molecular motors (akin to trucks) travel along thread-like roadways called microtubule tracks.

Since then, the team has shown that presenilin works in tandem with an enzyme called GSK-3β to control the motors' behavior, including the motors' movement and the way the motors bind with organic bubbles called vesicles that carry cargo such as proteins needed for cellular survival, signaling and repair.

The researchers' latest study, the May 22 paper in Human Molecular Genetics, provides details on how presenilin interacts with GSK-3β, and reports that a specific molecular structure within presenilin—a loop region—is necessary for proper traffic control.

New treatment avenues?

Together, the studies conducted over the years are providing insights that could one day inform new avenues for treating or preventing Alzheimer's, Gunawardena says.

Her research illustrates the complexities of neurological disease.

Presenilin has an important role in Alzheimer's: The protein aids in the production of beta-amyloid, which, when overproduced, causes plaques to form in patients' brains. But Gunawardena's work shows that presenilin may also have another role—this one positive—in regulating the flow of traffic within and preventing blockages that over time can lead to death of the cell and disease.

This may help explain why genetic mutations that result in a loss of presenilin's function are linked to Alzheimer's, she says.

"We are curious about the normal function of presenilin," she says. "What does this protein normally do? In the past, we have thought of it as being implicated in the production of beta-amyloid, but in fact, presenilin appears to also have a very different function independent of this. As we learn more about presenilin, it's possible that our research will result in new, more targeted opportunities for treating or preventing Alzheimer's disease."

Explore further: Preventing 'traffic jams' in brain cells

More information: Rupkatha Banerjee et al, The Presenilin loop region is essential for Glycogen synthase kinase 3 beta mediated functions on motor proteins during axonal transport, Human Molecular Genetics (2018). DOI: 10.1093/hmg/ddy190

Shermali Gunawardena et al. Presenilin controls kinesin-1 and dynein function during APP-vesicle transport in vivo, Human Molecular Genetics (2013). DOI: 10.1093/hmg/ddt237

Related Stories

Preventing 'traffic jams' in brain cells

May 28, 2013
Imagine if you could open up your brain and look inside. What you would see is a network of nerve cells called neurons, each with its own internal highway system for transporting essential materials between different parts ...

How problems with an Alzheimer's protein can jam up traffic in the brain

October 28, 2013
Scientists have known for some time that a protein called presenilin plays a role in Alzheimer's disease, and a new study reveals one intriguing way this happens.

Scientists reveal role for lysosome transport in Alzheimer's disease progression

August 7, 2017
Researchers from Yale University School of Medicine have discovered that defects in the transport of lysosomes within neurons promote the buildup of protein aggregates in the brains of mice with Alzheimer's disease. The study, ...

Mutation discovered to protect against Alzheimer's disease in mice

May 16, 2018
Researchers at the RIKEN Center for Brain Science have discovered a mutation that can protect against Alzheimer's disease in mice. Published in the scientific journal Nature Communications, the study found that a specific ...

Alzheimer's disease: Dual mechanism of actions of overactive and cytosolic BRCA1 in neuronal death

February 7, 2018
A new study suggests a dual mechanism of actions of overactive and cytosolic re-localized BRCA1, the major guardian of genomic stability, in neurons death by aberrant DNA damage response and presenilin 1 dysfunction in Alzheimer's ...

Study reveals mechanism behind most common form of inherited Alzheimer's disease

March 4, 2015
A study from researchers at Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH) reveals for the first time exactly how mutations associated with the most common form of inherited Alzheimer's disease ...

Recommended for you

Scientists discover why some people with brain markers of Alzheimer's have no dementia

August 16, 2018
A new study from The University of Texas Medical Branch at Galveston has uncovered why some people that have brain markers of Alzheimer's never develop the classic dementia that others do. The study is now available in the ...

Researchers identify new genes that may contribute to Alzheimer's disease

August 14, 2018
Researchers from Boston University School of Medicine, working with scientists across the nation on the Alzheimer's Disease Sequencing Project (ADSP), have discovered new genes that will further current understanding of the ...

Deaths from resident-to-resident incidents in dementia offers insights to inform policy

August 14, 2018
Analyzing the incidents between residents in dementia in long-term care homes may hold the key to reducing future fatalities among this vulnerable population, according to new research from the University of Minnesota School ...

Scientists propose a new lead for Alzheimer's research

August 14, 2018
A University of Adelaide-led team of scientists has suggested a potential link between iron in our cells and the rare gene mutations that cause Alzheimer's disease, which could provide new avenues for future research.

Eye conditions provide new lens screening for Alzheimer's disease

August 8, 2018
Alzheimer's disease is difficult to diagnose as well as treat, but researchers now have a promising new screening tool using the window to the brain: the eye.

Potential indicator for the early detection of dementias

August 7, 2018
Researchers at the University of Basel have discovered a factor that could support the early detection of neurodegenerative diseases such as Alzheimer's or Parkinson's. This cytokine is induced by cellular stress reactions ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.